Clear Impact logo R

Communicable Disease Surveillance: Monthly

Logo

Why Is This Important?

Measures

Most Recent Period
Current Actual Value
Current Target Value
Current Trend
Baseline % Change
I
Disease
Campylobacteriosis
Dec 2025
3
1
50%
I
Disease
Chlamydia
Dec 2025
26
2
-40%
I
Disease
Cryptosporidiosis
Dec 2025
0
1
0%
I
Disease
Gonorrhea (gonococcal infection)
Dec 2025
8
1
-62%
I
Disease
Haemophilus Influenzae (Invasive Disease)
Dec 2025
3
2
200%
I
Disease
Hepatitis A
Dec 2025
0
2
-100%
I
Disease
Hepatitis B-Chronic Non-Perinatal
Dec 2025
1
3
-75%
I
Disease
Hepatitis C-Perinatal Infection
Dec 2025
0
12
0%
I
Disease
Hepatitis C - Chronic Non-Perinatal
Dec 2025
5
1
-29%
I
Disease
Hepatitis E
Dec 2025
0
52
0%
I
Disease
Legionellosis
Dec 2025
0
1
0%
I
Disease
Lyme Disease
Dec 2025
0
3
0%
I
Disease
Rabies, human
Dec 2025
0
51
0%
I
Disease
Pertussis
Dec 2025
1
1
0%
I
Disease
Shigellosis
Dec 2025
1
1
0%
I
Disease
Streptococcal - Group A-Invasive
Dec 2025
1
1
0%
I
Disease
Syphilis
Dec 2025
0
1
0%
I
Disease
Varicella - Chickenpox
Dec 2025
0
1
0%
I
Disease
E. Coli, Shiga Toxin-Producing
Dec 2025
0
2
0%
I
Disease
Giardiasis
Dec 2025
0
1
0%
I
Disease
Hepatitis B Acute
Dec 2025
0
5
0%
I
Disease
Salmonellosis
Dec 2025
4
1
33%
I
Disease
Tuberculosis (TB), active infection
Dec 2025
0
8
0%
I
Disease
Meningitis-bacterial
Dec 2025
0
1
0%
I
Disease
Streptococcus pneumoniae - invasive antibiotic resistance unknown or non-resistant
Dec 2025
1
1
-50%
I
Disease
Influenza-associated hospitalization
Dec 2025
21
2
250%
I
Disease
Yersiniosis
Dec 2025
0
2
0%
I
Disease
Coccidioidomycosis - Valley Fever
Dec 2025
0
22
-100%
I
Disease
Malaria
Dec 2025
0
1
0%
I
Disease
Staphylococcal aureus - intermediate resistance to vancomycin (VISA)
Dec 2025
0
48
0%
I
Disease
Streptococcus pneumoniae - invasive antibiotic resistant/intermediate
Dec 2025
0
7
0%
I
Disease
Vibriosis
Dec 2025
0
4
0%
I
Disease
Tularemia
Dec 2025
0
42
0%
I
Disease
Hepatitis B-Perinatal Infection
Dec 2025
0
1
0%
I
Disease
Mpox
Dec 2025
0
24
0%
I
Disease
Spotted Fever Rickettsiosis, including Rocky Mountain spotted fever (RMSF)
Dec 2025
0
8
0%
I
Disease
Listeriosis
Dec 2025
0
13
0%
I
Disease
Measles
Dec 2025
0
12
0%
I
Disease
Hepatitis C - Acute
Dec 2025
0
19
-100%
I
Disease
Mumps
Dec 2025
0
22
0%
I
Disease
Cyclosporiasis
Dec 2025
0
4
0%
I
Disease
Anthrax
Oct 2025
0
81
0%
I
Disease
Arboviral neuroinvasive and non-neuroinvasive disease
Dec 2025
0
83
0%
I
Disease
Babesiosis
Dec 2025
0
24
0%
I
Disease
Botulism (foodborne)
Dec 2025
0
83
0%
I
Disease
Botulism (Infant)
Dec 2025
0
83
0%
I
Disease
Botulism (Wound)
Dec 2025
0
83
0%
I
Disease
Brucellosis
Dec 2025
0
16
0%
I
Disease
Candida auris
Dec 2025
0
4
0%
I
Disease
Chancroid
Dec 2025
0
83
0%
I
Disease
Chikungunya
Dec 2025
0
83
0%
I
Disease
Cholera
Dec 2025
0
83
0%
I
Disease
Creutfeldt-Jakob Disease
Dec 2025
0
84
0%
I
Disease
CPO - Colonization Screening
Dec 2025
0
1
0%
I
Disease
CPO
Dec 2025
0
2
0%
I
Disease
Diphtheria
Dec 2025
0
83
0%
I
Disease
Dengue
Dec 2025
0
82
0%
I
Disease
Ehrlichiosis
Dec 2025
0
38
0%
I
Disease
Eastern Equine Encephalitis Virus Disease
Dec 2025
0
83
0%
I
Disease
Hemolytic Uremic Syndrome (HUS)
Dec 2025
0
25
0%
I
Disease
Hantavirus
Dec 2025
0
83
0%
I
Disease
Hepatitis D (delta virus)
Dec 2025
0
83
0%
I
Disease
Influenza A - novel virus
Dec 2025
0
83
0%
I
Disease
Influenza-associated Pediatric Mortality
Dec 2025
0
20
0%
I
Disease
LaCrosse virus disease
Dec 2025
0
1
0%
I
Disease
Leprosy (Hansen disease)
Dec 2025
0
83
0%
I
Disease
Leptospirosis
Dec 2025
0
1
0%
I
Disease
Middle East Respiratory Syndrome (MERS)
Dec 2025
0
83
0%
I
Disease
Meningococcal disease
Dec 2025
0
11
0%
I
Disease
Plague
Dec 2025
0
47
0%
I
Disease
Psittacosis
Dec 2025
0
83
0%
I
Disease
Poliomyelitis
Dec 2025
0
47
0%
I
Disease
Powassan virus Disease
Dec 2025
0
83
0%
I
Disease
Q Fever
Dec 2025
0
72
0%
I
Disease
Rubella (congenital)
Dec 2025
0
83
0%
I
Disease
Rubella (not congenital)
Dec 2025
0
83
0%
I
Disease
Salmonella Typhi infection (typhoid fever)
Dec 2025
0
83
0%
I
Disease
Samonella Paratyphi Infection
Dec 2025
0
83
0%
I
Disease
Severe acute respiratory syndrome (SARS)
Dec 2025
0
83
0%
I
Disease
Smallpox
Dec 2025
0
83
0%
I
Disease
St. Louis Encephalitis Virus Disease
Dec 2025
0
83
0%
I
Disease
Streptococcal Disease, group B., in newborn
Dec 2025
0
60
0%
I
Disease
Streptococcal Toxic Shock Syndrome (STSS)
Dec 2025
0
83
0%
I
Disease
Tetanus
Dec 2025
0
83
0%
I
Disease
Toxic Shock Syndrome
Dec 2025
0
83
0%
I
Disease
Trichinellosis
Dec 2025
0
83
0%
I
Disease
Viral Hemorrhagic Fever (VHF)
Dec 2025
0
82
0%
I
Disease
West Nile Virus
Dec 2025
0
83
0%
I
Disease
Zika Virus Infection
Dec 2025
0
83
0%
I
Disease
Yellow Fever
Dec 2025
0
83
0%
I
Disease
Western Equine Encephalitis
Dec 2025
0
83
0%
I
Disease
Anaplasmosis-Anaplasma phagocytophilum
Dec 2025
0
3
0%
I
Disease
Cronobacter (infants less than 12 months of age)
Dec 2025
0
2
0%
I
Disease
Meliodiosis
Dec 2025
0
2
0%
I
Disease
Tuberculosis (TB), latent infection in children 2 years of age or younger)
Dec 2025
0
2
0%
I
Disease
Acute flaccid myelitis (AFM)
Dec 2025
0
2
0%
I
Disease
Free-living amoeba infection
Dec 2025
0
2
0%
I
Disease
Covid-19 Hospitalizations
Dec 2025
1
1
-67%
I
Disease
Respiratory sncytial virus (RSV)-associated hospitalization
Dec 2025
6
2
500%
I
Disease
Other arthropod-borne diseases
Dec 2025
0
1
-100%
Powered by Clear Impact

Clear Impact Suite is an easy-to-use, web-based software platform that helps your staff collaborate with external stakeholders and community partners by utilizing the combination of data collection, performance reporting, and program planning.

Scorecard Container Measure Action Actual Value Target Value Tag S A m/d/yy m/d/yyyy